| Home > Zentren > Zentrum für Innere Medizin > I. Medizinische Klinik und Poliklinik > Publikationen > 1999
Broering D, Mueller L, Gundlach M, Fischer L, Krupski G, Sterneck M, Helmke K, Ganschow K, Burdelski M, Rogiers X.:
Developments in living-related liver transplantation for children
Bulletin HPB 1999;3-4:4-9
Buggisch P.:
Aszites-TIPS versus Diuretikatherapie
Med.Welt 1999; 50: 521-524
Feucht HH, Zollner B, Schroter M, Polywka S, Buggisch P, Nolte H, Laufs R:
High rate of chronicity in HCV infection determined by antibody confirmatory assay and PCR in 4110 patients during long-term follow-up.
J Clin Virol 1999; 13: 43-51
http://www.ncbi.nlm.nih.gov/sites/entrez/10405891
Fischer L, Sterneck M, Claus M, Costard-Jäckle A, Fleischer B, Herbst H, Rogiers X, Broelsch CE:
Transmission of malaria tertiana by multi-organ donation
Clinical Transplantation 1999;13:491-495
http://www.ncbi.nlm.nih.gov/sites/entrez/10617239
Fischer L, Sterneck M, Feucht HH, Schuhmacher C, Malagó M, Rogiers X, Laufs R, Broelsch CE.:
Hepatitis G virus infection in liver transplant recipients
Transplantation Proceedings 1999;31(1/2):496-499
http://www.ncbi.nlm.nih.gov/sites/entrez/10083208
Fischer L, Sterneck M, Müller-Ruchholtz C, Gish R, Will H.:
Hepatitis B virus variants associated with clinically severe recurrence after liver transplantation
Transplantation Proceedings 1999;31(1/2):492-493
http://www.ncbi.nlm.nih.gov/sites/entrez/10083206
Fischer L, Sterneck M, Rogiers X:
Liver Transplantation for acute liver failure
European Journal of Gastroenterology and Hepatology 1999;11:985-90
http://www.ncbi.nlm.nih.gov/sites/entrez/10503834
Fischer L, Sterneck M, Valentin-Gamazo C, Feucht HH, Malagó M, Broelsch CE.:
Treatment of severe recurrent hepatitis C after liver transplantation with ribavirin plus interferon A
Transplantation Proceedings 1999;31:494-495
http://www.ncbi.nlm.nih.gov/sites/entrez/10083207
Günther S, Fischer L, Sterneck M, Pult I, Will H:
Naturally occuring hepatitis B virus variants
Advances in Virus Research 1999; 52:25-137
http://www.ncbi.nlm.nih.gov/sites/entrez/10384235
Günther S, von Breunig F, Santantonio L, Jung MC , Gaeta GB, Fischer L, Sterneck M, Will H.:
Absence of mutations in the YMDD motif/B region of the hepatitis B virus polymerase in famciclovir therapy failure
Journal of Hepatology 1999;30:749-754
http://www.ncbi.nlm.nih.gov/sites/entrez/10365797
Hermans G, Denzer U, Lohse AW, Raus J, Stinissen P:
Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.
J Autoimmunity 1999; 13: 233-246
http://www.ncbi.nlm.nih.gov/sites/entrez/10479392
Kanzler S, Lohse AW, Keil A, Henninger J, Dienes HP, Schirmacher P, Rose-John S, Meyer zum Büschenfelde KH, Blessing M:
TGF-ß1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis.
Am J Physiol 1999; 276: G1059-68
http://www.ncbi.nlm.nih.gov/sites/entrez/10198351
Kanzler S, Weidemann C, Gerken G, Löhr HF, Galle PR, Meyer zum Büschenfelde KH, Lohse AW:
Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis.
J Hepatol 1999; 31: 635 - 640
http://www.ncbi.nlm.nih.gov/sites/entrez/10551386
Knolle P, Germann T, Treichel U, Uhrig A, Schmitt E, Hegenbarth S, Lohse AW, Gerken G:
Endotoxin down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells.
J Immunol 1999; 162: 1401-1407
http://www.ncbi.nlm.nih.gov/sites/entrez/9973395
Knolle P, Schmitt E, Jin SC, Germann T, Duchmann R, Hegenbarth S, Gerken G, Lohse AW:
Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells.
Gastroenterology 1999 ; 116: 1428-1440
http://www.ncbi.nlm.nih.gov/sites/entrez/10348827
Lohse AW, Meyer zum Büschenfelde KH, Franz B, Kanzler S, Gerken G, Dienes HP:
Characterisation of the 'overlap syndrome' of primary biliary cirrhosis (PBC) and autoimmune hepatitis (AIH) in genetically susceptible individuals
Hepatology 1999; 29: 1078-1084
http://www.ncbi.nlm.nih.gov/sites/entrez/10094950
Lohse AW, Obermayer-Straub P, Gerken G, Brunner S, Altes U, Dienes HP, Manns M, Meyer zum Büschenfelde KH:
Development of cytochrome p450 2D6 specific LKM-autoantibodies following transplantation for Wilson's disease - possible association with a steroid-resistant transplant rejection episode.
J Hepatol 1999 ; 31: 149-155
http://www.ncbi.nlm.nih.gov/sites/entrez/10424295
Raabe A, Scheel G, Seegers B, Buchert R, de Wit M:
Methodische Untersuchungen zum Nachweis von Rezidiven des R1H-Tumors nach fraktionierter Strahlentherapie: Vorteile und Grenzen der Positronen-Emissions-Tomographie (PET).
Exp Strahlenther Klin Strahlenbiol 1999: 154-156
Santantonio T, Günther S, Sterneck M, Rendina M, Messner M, Launois B, Francavilla A, Pastore G, Will H.:
Liver graft infection by HBV S-gene mutants in transplant patients receiving long-term HBIg prophylaxis
Hepatogastroenterology 1999;46(27):1848-54
Schramm C, Helmreich-Becker I, Schirmacher P, Gerken G, Meyer zum Büschenfelde KH, Lohse AW:
Combined immunosuppressive therapy with azathioprine and prednisolone in primary sclerosing cholangitis.
Ann Intern Med 1999; 131: 943-946
http://www.ncbi.nlm.nih.gov/sites/entrez/10610645
Schramm C, Wanitschke R, Galle PR:
Thiamine for the treatment of nucleoside analogue-induced severe lactic acidosis.
Eur J Anaesthesiol 1999; 16: 733-735
http://www.ncbi.nlm.nih.gov/sites/entrez/10583359
Schulz KH, Pöhlmann U, Kjer S, Kuhlencordt R, Sterneck M, Rogiers X, Broelsch CE.:
Lebensqualität und Rezidivquote nach Lebertransplantation (LTX) bei Patienten mit Äthyltoxischer Leberzirrhose - Ein Überblick und eine Katamnestische Studie
Transplant Link 1 Supplement 1999, 1-21
Sterneck M.:
Moderne Therapie der chronischen Hepatitis B
Medizinische Welt 1999;50:321-326
Sterneck M.:
Therapie der posthepatitischen Leberzirrhose
Hamburger Ärzteblatt 1999;54:10-12
Wirtz S, Finotto S, Kanzler S, Lohse AW, Blessing M, Lehr HA, Galle PR, Neurath M:
Cutting Edge: Chronic intestinal inflammation in STAT-4 transgenic mice: characterization of disease and adoptive transfer by TNF-plus IFNgamma-producing CD4+ T cells that respond to bacterial antigens.
J Immunol 1999; 162: 1884-1888
http://www.ncbi.nlm.nih.gov/sites/entrez/9973454
